Total Payments
$4,136
2024 Payments
$1,491
Companies
19
Transactions
287
Medicare Patients
6,706
Medicare Billing
$371,938
Payment Breakdown by Category
Food & Beverage$3,938 (95.2%)
Education$197.97 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,938 | 284 | 95.2% |
| Education | $197.97 | 3 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,164 | 62 | $0 (2024) |
| ABBVIE INC. | $1,129 | 126 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $329.04 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $325.16 | 23 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $265.45 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $225.94 | 10 | $0 (2024) |
| Lilly USA, LLC | $143.15 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $101.35 | 5 | $0 (2024) |
| GENZYME CORPORATION | $92.27 | 4 | $0 (2023) |
| UCB, Inc. | $74.49 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,491 | 101 | Janssen Biotech, Inc. ($296.14) |
| 2023 | $1,163 | 76 | Janssen Biotech, Inc. ($516.66) |
| 2022 | $982.38 | 73 | Janssen Biotech, Inc. ($324.69) |
| 2021 | $499.42 | 37 | AbbVie Inc. ($204.09) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.23 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.04 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.23 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $1.39 | General |
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.72 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $134.74 | General |
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,798 | 3,344 | $368,902 | $98,784 |
| 2022 | 14 | 1,724 | 3,109 | $354,037 | $95,186 |
| 2021 | 14 | 1,563 | 3,004 | $323,153 | $90,126 |
| 2020 | 17 | 1,621 | 2,891 | $317,516 | $87,842 |
Total Patients
6,706
Total Services
12,348
Medicare Billing
$371,938
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 509 | 598 | $86,710 | $28,769 | 33.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 216 | 250 | $56,500 | $15,568 | 27.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 331 | 408 | $68,544 | $12,726 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 125 | $27,250 | $9,126 | 33.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 61 | 76 | $26,980 | $7,755 | 28.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 105 | 120 | $17,160 | $6,438 | 37.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 265 | 1,528 | $42,784 | $6,115 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $12,470 | $3,149 | 25.3% |
| 67850 | Destruction of growth of eyelid margin, 1.0 cm or less | Office | 2023 | 18 | 19 | $8,265 | $2,422 | 29.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $7,876 | $2,034 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 64 | $5,568 | $1,997 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,951 | $1,927 | 27.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 23 | $1,748 | $731.73 | 41.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 32 | $96.00 | $26.00 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 457 | 537 | $77,865 | $25,423 | 32.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 205 | 247 | $55,822 | $15,769 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 307 | 378 | $63,504 | $11,863 | 18.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 62 | 87 | $30,885 | $9,042 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 122 | $26,596 | $8,321 | 31.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 111 | 120 | $17,160 | $6,371 | 37.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 236 | 1,339 | $37,492 | $5,296 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $11,585 | $3,243 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $11,825 | $2,983 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 86 | 92 | $8,075 | $2,858 | 35.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 19 | $6,802 | $2,218 | 32.6% |
About Eric Gold, PA
Eric Gold, PA is a Physician Assistant healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043326119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Gold, PA has received a total of $4,136 in payments from pharmaceutical and medical device companies, with $1,491 received in 2024. These payments were reported across 287 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,938).
As a Medicare-enrolled provider, Gold has provided services to 6,706 Medicare beneficiaries, totaling 12,348 services with total Medicare billing of $371,938. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Glens Falls, NY
- Active Since 08/22/2006
- Last Updated 10/28/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1043326119
Products in Payments
- TREMFYA (Drug) $1,116
- SKYRIZI (Biological) $903.77
- Sotyktu (Drug) $329.04
- COSENTYX (Drug) $273.37
- Zoryve (Drug) $265.45
- DUPIXENT (Biological) $148.63
- TALTZ (Drug) $143.15
- HUMIRA (Biological) $125.63
- RINVOQ (Biological) $99.85
- Ilumya (Biological) $60.75
- Cimzia (Drug) $57.55
- COSENTYX (Biological) $51.79
- REMICADE (Biological) $48.11
- LIBTAYO (Biological) $44.99
- Otezla (Drug) $43.38
- AKLIEF (Drug) $42.29
- OPZELURA (Drug) $38.07
- EUCRISA (Drug) $37.49
- VTAMA (Drug) $28.17
- Erivedge (Biological) $19.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Glens Falls
Miss. Marissa Chaffee, Pa-C, PA-C
Physician Assistant — Payments: $2,231
Physician Assistant $2,231
Howard Ritz, Pa-C, PA-C
Physician Assistant — Payments: $1,999
Physician Assistant $1,999
Haley Decker, Pa-C, PA-C
Physician Assistant — Payments: $1,771
Physician Assistant $1,771
Kelly Reed, Pa, PA
Physician Assistant — Payments: $1,387
Physician Assistant $1,387
Joanne Cooper, Rpa-C, RPA-C
Physician Assistant — Payments: $1,380
Physician Assistant $1,380
Kathleen Crotty, Pa-C, PA-C
Physician Assistant — Payments: $1,352
Physician Assistant $1,352